Get started
SUVEN PHARMACEUTICALS LTDSUVEN PHARMACEUTICALS LTDSUVEN PHARMACEUTICALS LTD

SUVEN PHARMACEUTICALS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SUVENPHAR chart


Full chart

SUVENPHAR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪297.18 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
120.50
Basic EPS (TTM)
9.55 INR
Net income (FY)
‪3.00 B‬ INR
Revenue (FY)
‪10.36 B‬ INR
Shares float
‪101.49 M‬
Beta (1Y)
0.68

Employees


Employees (FY)
‪1.05 K‬
Change (1Y)
‪−1.52 K‬ −59.16%
Revenue / Employee (1Y)
‪9.85 M‬ INR
Net income / Employee (1Y)
‪2.85 M‬ INR

About SUVEN PHARMACEUTICALS LTD


Sector
Producer Manufacturing
Industry
Industrial Conglomerates
CEO
Sudhir Kumar Singh
Website
suvenpharm.com
Headquarters
Hyderabad
Founded
2018
ISIN
INE03QK01018
FIGI
BBG00S6SV6M8
Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SUVENPHAR news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SUVENPHAR is 1,143.50 INR — it has increased by 1.69% in the past 24 hours. Watch SUVEN PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUVEN PHARMACEUTICALS LTD stocks are traded under the ticker SUVENPHAR.
SUVENPHAR stock has fallen by −3.86% compared to the previous week, the month change is a −9.14% fall, over the last year SUVEN PHARMACEUTICALS LTD has showed a 63.50% increase.
We've gathered analysts' opinions on SUVEN PHARMACEUTICALS LTD future price: according to them, SUVENPHAR price has a max estimate of 1,435.00 INR and a min estimate of 1,435.00 INR. Watch SUVENPHAR chart and read a more detailed SUVEN PHARMACEUTICALS LTD stock forecast: see what analysts think of SUVEN PHARMACEUTICALS LTD and suggest that you do with its stocks.
SUVENPHAR reached its all-time high on Dec 2, 2024 with the price of 1,360.00 INR, and its all-time low was 87.60 INR and was reached on Mar 24, 2020. View more price dynamics on SUVENPHAR chart.
See other stocks reaching their highest and lowest prices.
SUVENPHAR stock is 16.39% volatile and has beta coefficient of 0.68. Track SUVEN PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is SUVEN PHARMACEUTICALS LTD there?
Today SUVEN PHARMACEUTICALS LTD has the market capitalization of ‪291.46 B‬, it has decreased by −10.48% over the last week.
Yes, you can track SUVEN PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
SUVEN PHARMACEUTICALS LTD is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
SUVENPHAR net income for the last quarter is ‪822.10 M‬ INR, while the quarter before that showed ‪607.70 M‬ INR of net income which accounts for 35.28% change. Track more SUVEN PHARMACEUTICALS LTD financial stats to get the full picture.
SUVEN PHARMACEUTICALS LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.21% and 6.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has ‪1.05 K‬ employees. See our rating of the largest employees — is SUVEN PHARMACEUTICALS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUVEN PHARMACEUTICALS LTD EBITDA is ‪3.22 B‬ INR, and current EBITDA margin is 39.68%. See more stats in SUVEN PHARMACEUTICALS LTD financial statements.
Like other stocks, SUVENPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUVEN PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUVEN PHARMACEUTICALS LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUVEN PHARMACEUTICALS LTD stock shows the buy signal. See more of SUVEN PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.